RCM
MYOV
RA Capital Management’s Myovant Sciences Ltd. MYOV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-6,166,875
| Closed | -$32.1M | – | 39 |
|
|
2019
Q3 | $32.1M | Sell |
6,166,875
-378,767
| -6% | -$1.97M | 1.91% | 16 |
|
|
2019
Q2 | $59.2M | Buy |
6,545,642
+3,001,415
| +85% | +$27.2M | 3.18% | 9 |
|
|
2019
Q1 | $84.6M | Sell |
3,544,227
-167,322
| -5% | -$3.99M | 3.65% | 9 |
|
|
2018
Q4 | $60.9M | Buy |
3,711,549
+259,690
| +8% | +$4.26M | 3.55% | 9 |
|
|
2018
Q3 | $91.6M | Buy |
3,451,859
+621,404
| +22% | +$16.5M | 4.9% | 6 |
|
|
2018
Q2 | $64.7M | Hold |
2,830,455
| – | – | 4.2% | 7 |
|
|
2018
Q1 | $60.2M | Hold |
2,830,455
| – | – | 4.61% | 4 |
|
|
2017
Q4 | $35.8M | Hold |
2,830,455
| – | – | 2.99% | 10 |
|
|
2017
Q3 | $43.8M | Buy |
2,830,455
+22,905
| +0.8% | +$354K | 3.96% | 9 |
|
|
2017
Q2 | $32.8M | Buy |
2,807,550
+459,128
| +20% | +$5.37M | 3.77% | 9 |
|
|
2017
Q1 | $27.6M | Buy |
2,348,422
+848,422
| +57% | +$9.96M | 3.38% | 8 |
|
|
2016
Q4 | $18.7M | Buy |
+1,500,000
| New | +$18.7M | 2.64% | 11 |
|